Company registration number 13939051 (England and Wales)
MED VIBES LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
PAGES FOR FILING WITH REGISTRAR
MED VIBES LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
MED VIBES LTD
BALANCE SHEET
AS AT 28 FEBRUARY 2026
28 February 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
4
303,525
368,658
Current assets
Debtors
5
1,039
1,125
Cash at bank and in hand
4,541
4,900
5,580
6,025
Creditors: amounts falling due within one year
6
(1,309,539)
(1,216,831)
Net current liabilities
(1,303,959)
(1,210,806)
Total assets less current liabilities
(1,000,434)
(842,148)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(1,000,534)
(842,248)
Total equity
(1,000,434)
(842,148)

For the financial year ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 6 October 2026 and are signed on its behalf by:
Mr  J U Sanchez-Robles
Director
Company registration number 13939051 (England and Wales)
MED VIBES LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
- 2 -
1
Accounting policies
Company information

Med Vibes Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Lester Aldridge LLP, Oxford Road, Bournemouth, United Kingdom, BH8 8EX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Despite a net liability at the balance sheet date, Med Vibes Ltd is considered to be a going concern at the time of approving the financial statements, given substantial liabilities owed ttrueo two directors committed to ongoing financial assistance.

 

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
15% reducing balance method
Fixtures and fittings
25% reducing balance method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

MED VIBES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

There were no employees during the current or previous year.

MED VIBES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
- 4 -
4
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Total
£
£
£
Cost
At 1 March 2025 and 28 February 2026
393,730
184,919
578,649
Depreciation and impairment
At 1 March 2025
123,422
86,569
209,991
Depreciation charged in the year
40,545
24,588
65,133
At 28 February 2026
163,967
111,157
275,124
Carrying amount
At 28 February 2026
229,763
73,762
303,525
At 28 February 2025
270,308
98,350
368,658
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Prepayments and accrued income
1,039
1,125
6
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
763
749
Other creditors
1,212,002
1,111,050
Accruals and deferred income
96,774
105,032
1,309,539
1,216,831
7
Related party transactions

Included in other creditors is an amount of £1,212,002 (2025: £1,111,050) owed to the directors by the company.

2026-02-282025-03-01falsefalsefalse09 October 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr F N GarciaMr J U Sanchez-Robles0139390512025-03-012026-02-28139390512026-02-28139390512025-02-2813939051core:PlantMachinery2026-02-2813939051core:FurnitureFittings2026-02-2813939051core:PlantMachinery2025-02-2813939051core:FurnitureFittings2025-02-2813939051core:CurrentFinancialInstrumentscore:WithinOneYear2026-02-2813939051core:CurrentFinancialInstrumentscore:WithinOneYear2025-02-2813939051core:ShareCapital2026-02-2813939051core:ShareCapital2025-02-2813939051core:RetainedEarningsAccumulatedLosses2026-02-2813939051core:RetainedEarningsAccumulatedLosses2025-02-2813939051bus:Director22025-03-012026-02-2813939051core:PlantMachinery2025-03-012026-02-2813939051core:FurnitureFittings2025-03-012026-02-2813939051core:PlantMachinery2025-02-2813939051core:FurnitureFittings2025-02-28139390512025-02-2813939051core:CurrentFinancialInstruments2026-02-2813939051core:CurrentFinancialInstruments2025-02-2813939051bus:PrivateLimitedCompanyLtd2025-03-012026-02-2813939051bus:SmallCompaniesRegimeForAccounts2025-03-012026-02-2813939051bus:FRS1022025-03-012026-02-2813939051bus:AuditExemptWithAccountantsReport2025-03-012026-02-2813939051bus:Director12025-03-012026-02-2813939051bus:FullAccounts2025-03-012026-02-28xbrli:purexbrli:sharesiso4217:GBP